Havencrest Healthcare Partners, L.P., 10% Owner at Oncology Institute, Inc. (TOI), sold 242,754 shares at $4.26 ($1.1M) on 2022-11-01, disclosed to the SEC on 2022-11-02.
Open-market sale of $1.1M TOI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.69 | 41,855 | $196K | 18.7% |
| 2 | $4.69 | 41,855 | $196K | 18.7% |
| 3 | $4.26 | 50,272 | $214K | 20.4% |
| 4 | $4.26 | 50,272 | $214K | 20.4% |
| 5 | $3.94 | 58,500 | $230K | 21.9% |
| Total | $4.33 avg | 242,754 |
| $1.1M |
| 100% |
| Filing → |
| TOI | SELL | 2022-11-15 | $1.7M | — | Filing → |
| TOI | SELL | 2022-11-10 | $700K | — | Filing → |
| TOI | SELL | 2022-11-07 | $459K | — | Filing → |